Syra health's "syrenity" research study protocol approved by institutional review board

Carmel, ind. , april 3, 2024 /prnewswire/ -- syra health corp. (nasdaq: syra) ("syra health" or the "company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that pearl institutional review board (irb) has approved the company's research study protocol for "syrenity," syra health's prevention-focused mental and behavioral health platform.
SYRA Ratings Summary
SYRA Quant Ranking